Thioguanine or tioguanine

A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.

A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.

A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.

InformationCH7233163 is a non-covalent ATP competitive inhibitor ofEGFR-tyrosine kinasewith antitumor activities against tumor with EGFR-Del19/T790M/C797S.TargetsEGFRIn vitroCH7233163 shows potent antitumor activities against tumor with

Cot inhibitor-2 is a potent, selective and orally active cot (Tpl2/MAP3K8) inhibitor with an IC 50 of 1.6 nM. Cot inhibitor-2 inhibts TNF-α production in LPS-stimulated human whole blood with an IC 50 of 0.3 μMIn VivoCot inhibitor-2 (compound 34) is

An active metabolite of proguanil, produced by CYP2C19 an inhibitor of dihydrofolate reductase (Kis = 0.3 and 1.5 nM for Plasmodium and human forms, respectively).

An active metabolite of proguanil, produced by CYP2C19 an inhibitor of dihydrofolate reductase (Kis = 0.3 and 1.5 nM for Plasmodium and human forms, respectively).

A synthetic intermediate for pharmaceutical synthesis.

A cell-permeable thienopyridinylcarboxamide compound that selectively and directly binds to forkhead box M1 (FOXM1) in a 1:1 stoichiometry and reversibly blocks its DNA binding activity (IC 50 = 22.5 &#181M).

Immunotag™ Human TP/TXA2R (Thromboxane Receptor) ELISA

Immunotag™ Rat Rt3 (Reverse Triiodothyronine) ELISA

Synonyms: L-Thz-OH L-Thiazolidine-4-carboxylic acid (R)-Thiazolidine-4-carboxylic acid Purity Limit: &ge 98.5% (assay) CAS No.